As of Sep 29
| -0.26 / -5.86%|
The 5 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 7.33, with a high estimate of 14.00 and a low estimate of 5.50. The median estimate represents a +75.48% increase from the last price of 4.18.
The current consensus among 7 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.